tiprankstipranks
Advertisement
Advertisement

CAPR Stock Latest News

3 ‘Perfect 10’ Smart Score Stocks to Buy this Week, 3/30/26, According to Analysts
Market News3 ‘Perfect 10’ Smart Score Stocks to Buy this Week, 3/30/26, According to Analysts
21d ago
XEL
CAPR
Capricor Therapeutics price target raised to $43 from $41 at Roth Capital
PremiumThe Fly
Capricor Therapeutics price target raised to $43 from $41 at Roth Capital
1M ago
CAPR
Capricor Therapeutics Nears Key Milestones After Earnings Call
PremiumCompany Announcements
Capricor Therapeutics Nears Key Milestones After Earnings Call
1M ago
CAPR
Capricor selloff today a buying opportunity, says Roth Capital
PremiumThe Fly
Capricor selloff today a buying opportunity, says Roth Capital
1M ago
CAPR
Capricor Therapeutics price target raised to $51 from $48 at Alliance Global
PremiumThe Fly
Capricor Therapeutics price target raised to $51 from $48 at Alliance Global
1M ago
CAPR
Capricor Therapeutics price target raised to $63 from $50 at B. Riley
PremiumThe FlyCapricor Therapeutics price target raised to $63 from $50 at B. Riley
1M ago
CAPR
Capricor Therapeutics price target raised to $58 from $45 at Piper Sandler
Premium
The Fly
Capricor Therapeutics price target raised to $58 from $45 at Piper Sandler
1M ago
CAPR
Capricor Therapeutics reports Q4 EPS (62c), consensus (55c)
Premium
The Fly
Capricor Therapeutics reports Q4 EPS (62c), consensus (55c)
1M ago
CAPR
Capricor Therapeutics options imply 4.2% move in share price post-earnings
PremiumThe Fly
Capricor Therapeutics options imply 4.2% move in share price post-earnings
1M ago
CAPR
Deramiocel’s De‑Risked Path to Approval and Expanded DMD Opportunity Underpin Buy on CAPR
PremiumRatings
Deramiocel’s De‑Risked Path to Approval and Expanded DMD Opportunity Underpin Buy on CAPR
1M ago
CAPR
Capricor announces additional analyses, outcomes from Phase 3 HOPE-3 trial
PremiumThe Fly
Capricor announces additional analyses, outcomes from Phase 3 HOPE-3 trial
1M ago
CAPR
Midday Fly By: HP Enterprise reports Q1 beat, BioNTech announces new company
PremiumThe Fly
Midday Fly By: HP Enterprise reports Q1 beat, BioNTech announces new company
1M ago
ABM
CNC
Capricor Advances Deramiocel BLA Review for Duchenne DMD
PremiumCompany AnnouncementsCapricor Advances Deramiocel BLA Review for Duchenne DMD
1M ago
8K
CAPR
Capricor announces establishment of new PDUFA date for dermiocel BLA
Premium
The Fly
Capricor announces establishment of new PDUFA date for dermiocel BLA
1M ago
CAPR
CAPR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
CAPR Earnings this Week: How Will it Perform?
1M ago
CAPR
FDA review process for accelerated approval narrows, less predictable, WSJ says
PremiumThe Fly
FDA review process for accelerated approval narrows, less predictable, WSJ says
2M ago
CAPR
IRON
Capricor expects to submit updates to BLA in February 2026
PremiumThe Fly
Capricor expects to submit updates to BLA in February 2026
3M ago
CAPR
Capricor Therapeutics: HOPE-3 Success, De-Risked Regulatory Path, and Priority Review Voucher Upside Support Buy Rating
PremiumRatings
Capricor Therapeutics: HOPE-3 Success, De-Risked Regulatory Path, and Priority Review Voucher Upside Support Buy Rating
3M ago
CAPR
Capricor Therapeutics price target raised to $50 from $21 at B. Riley
PremiumThe Fly
Capricor Therapeutics price target raised to $50 from $21 at B. Riley
4M ago
CAPR
Capricor Therapeutics price target raised to $45 from $20 at Piper Sandler
PremiumThe FlyCapricor Therapeutics price target raised to $45 from $20 at Piper Sandler
4M ago
CAPR
Capricor Therapeutics management to meet with Oppenheimer
Premium
The Fly
Capricor Therapeutics management to meet with Oppenheimer
4M ago
CAPR
Capricor Therapeutics price target raised to $54 from $22 at Oppenheimer
Premium
The Fly
Capricor Therapeutics price target raised to $54 from $22 at Oppenheimer
4M ago
CAPR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >